Bradlow, Richard C. J.
Berk, Michael
Kalivas, Peter W.
Back, Sudie E.
Kanaan, Richard A. http://orcid.org/0000-0003-0992-1917
Funding for this research was provided by:
University of Melbourne
Article History
Accepted: 17 February 2022
First Online: 22 March 2022
Change Date: 28 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40263-022-00925-1
Declarations
:
: No sources of funding were obtained to assist with the preparation of this article. Open Access funding enabled and organized by CAUL and its Member Institutions.
: Bradlow, R., Kalivas, S., and Back, S., declare that they have no conflicts of interest. Professor Michael Berk received Grant/Research Support: NHMRC Senior Principal Research Fellowship (1156072), Cooperative Research Centre Speaker remuneration: Astra Zeneca Bristol Myers Squibb Eli Lilly Glaxo SmithKline Lundbeck Pfizer Sanofi Synthelabo Servier Solvay Wyeth. Consultant payments: Servier, Lundbeck, Otsuka, Milken Institute, Sandoz/SASOP, Allori for Eisai, Janssen, 28th Symposium Controversias Psych, Mental Health Commission Govt Aust, ASCP, Medplan Canada, European Psych Assoc, Abbot, AstraZeneca, Merck, Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Janssen, Thieme Pharmacopsychiatry Journal – Advisory Board Member, BeyondBlue – Research Advisory Committee Member, Australian Early Psychosis Collaborative Consortium (AEPCC) Advisory Council Member. Patents: Michael Berk is a co-inventor of two patents regarding the use of NAC and related compounds for psychiatric indications, which, while assigned to the Mental Health Research Institute, could lead to personal remuneration upon a commercialisation event. Professor Kanaan has received grants from The Defense Health Foundation and the Sir Edward Dunlop Medical Research Fund for a clinical trial of NAC in PTSD. He has also received the donation of NAC from Bioadvantex Pharma for the trial.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Every author has made substantial contributions to the conception, planning, drafting, and revision of this manuscript, to analysis and interpretation of the data, and has approved the final submitted version of the manuscript.